R Cady

Summary

Publications

  1. doi request reprint Advances in drug development for acute migraine
    Ryan J Cady
    Center of Biomedical Life Sciences, Missouri State University, Springfield, MO 65807, USA
    Drugs 72:2187-205. 2012
  2. doi request reprint Two center, randomized pilot study of migraine prophylaxis comparing paradigms using pre-emptive frovatriptan or daily topiramate: research and clinical implications
    Roger K Cady
    Headache Care Center, 3805 S Kansas Expressway, Springfield, MO 65807, USA
    Headache 52:749-64. 2012
  3. doi request reprint The bowel and migraine: update on celiac disease and irritable bowel syndrome
    Roger K Cady
    Headache Care Center, 3805 South Kansas Expressway, Springfield, MO 65807, USA
    Curr Pain Headache Rep 16:278-86. 2012
  4. doi request reprint Postmarketing migraine survey of frovatriptan: effectiveness and tolerability vs previous triptans, NSAIDs or a combination
    Roger K Cady
    Headache Care Center, 1230 E Kingsley, Springfield, MO 65804, USA
    Curr Med Res Opin 25:2711-21. 2009
  5. doi request reprint OnabotulinumtoxinA (botulinum toxin type-A) in the prevention of migraine
    Roger K Cady
    Headache Care Center, 3805 S Kansas Expressway, Springfield, MO 65807, USA
    Expert Opin Biol Ther 10:289-98. 2010
  6. doi request reprint Multi-center comparison of response to a single tablet of sumatriptan 85 mg and naproxen 500 mg vs usual therapy treating multiple migraine attacks as measured by the completeness of response survey
    Roger Cady
    Headache Care Center, Springfield, MO, USA
    Headache 51:961-70. 2011
  7. ncbi request reprint Symptoms of cutaneous sensitivity pre-treatment and post-treatment: results from the rizatriptan TAME studies
    R Cady
    Banyan Group Inc, Springfield, MO 65807, USA
    Cephalalgia 27:1055-60. 2007
  8. ncbi request reprint Sumatriptan nasal spray and cognitive function during migraine: results of an open-label study
    K Farmer
    Headache Care Center, Springfield, MO 65804, USA
    Headache 41:377-84. 2001
  9. ncbi request reprint Long-term efficacy and tolerability of rizatriptan wafers in migraine
    R Cady
    Headache Care Center, Springfield, Missouri, USA
    MedGenMed 3:1. 2001
  10. ncbi request reprint A pilot study to measure cognitive efficiency during migraine
    K Farmer
    Headache Care Center, Springfield, MO 65804, USA
    Headache 40:657-61. 2000

Collaborators

Detail Information

Publications17

  1. doi request reprint Advances in drug development for acute migraine
    Ryan J Cady
    Center of Biomedical Life Sciences, Missouri State University, Springfield, MO 65807, USA
    Drugs 72:2187-205. 2012
    ..Based on clinical observations, this article explores future acute treatment needs, drugs in development for acute migraine, and new products that deliver established drugs to improve treatment response...
  2. doi request reprint Two center, randomized pilot study of migraine prophylaxis comparing paradigms using pre-emptive frovatriptan or daily topiramate: research and clinical implications
    Roger K Cady
    Headache Care Center, 3805 S Kansas Expressway, Springfield, MO 65807, USA
    Headache 52:749-64. 2012
    ..The study compares the paradigms of pre-emptive use of frovatriptan, a drug approved for acute migraine, and the daily use of topiramate, a Federal Drug Administration-approved and -accepted standard for migraine prophylaxis...
  3. doi request reprint The bowel and migraine: update on celiac disease and irritable bowel syndrome
    Roger K Cady
    Headache Care Center, 3805 South Kansas Expressway, Springfield, MO 65807, USA
    Curr Pain Headache Rep 16:278-86. 2012
    ..What appears to link migraine, IBS, and CD is a disease model of a genetically sensitive nervous system transformed into one that is hypervigilant, and that over time can often develop disabling and pervasive disease...
  4. doi request reprint Postmarketing migraine survey of frovatriptan: effectiveness and tolerability vs previous triptans, NSAIDs or a combination
    Roger K Cady
    Headache Care Center, 1230 E Kingsley, Springfield, MO 65804, USA
    Curr Med Res Opin 25:2711-21. 2009
    ..5-mg tablets (in 1-3 migraines) in patients with migraine previously using other triptans, analgesics/nonsteroidal anti-inflammatory drugs (NSAIDs), or triptans and NSAIDs (T+NSAIDs)...
  5. doi request reprint OnabotulinumtoxinA (botulinum toxin type-A) in the prevention of migraine
    Roger K Cady
    Headache Care Center, 3805 S Kansas Expressway, Springfield, MO 65807, USA
    Expert Opin Biol Ther 10:289-98. 2010
    ..Migraine is a highly prevalent disorder with the potential to progress into a chronic disease. The disability and health effects associated with frequent episodes of migraine underscore the value of preventive pharmacotherapy...
  6. doi request reprint Multi-center comparison of response to a single tablet of sumatriptan 85 mg and naproxen 500 mg vs usual therapy treating multiple migraine attacks as measured by the completeness of response survey
    Roger Cady
    Headache Care Center, Springfield, MO, USA
    Headache 51:961-70. 2011
    ..To investigate a broad definition of migraine resolution that extends beyond specific migraine-associated diagnostic symptoms as measured by the Completeness of Response Survey...
  7. ncbi request reprint Symptoms of cutaneous sensitivity pre-treatment and post-treatment: results from the rizatriptan TAME studies
    R Cady
    Banyan Group Inc, Springfield, MO 65807, USA
    Cephalalgia 27:1055-60. 2007
    ..The presence of SCS at baseline did not predict pain-free response, but presence of SCS at 2 h correlated with lack of a 2-h pain-free response...
  8. ncbi request reprint Sumatriptan nasal spray and cognitive function during migraine: results of an open-label study
    K Farmer
    Headache Care Center, Springfield, MO 65804, USA
    Headache 41:377-84. 2001
    ..001). CONCLUSIONS: Sumatriptan nasal spray, 20 mg, restored migraine-related cognitive function and clinical disability...
  9. ncbi request reprint Long-term efficacy and tolerability of rizatriptan wafers in migraine
    R Cady
    Headache Care Center, Springfield, Missouri, USA
    MedGenMed 3:1. 2001
    ..Rizatriptan wafers were well tolerated...
  10. ncbi request reprint A pilot study to measure cognitive efficiency during migraine
    K Farmer
    Headache Care Center, Springfield, MO 65804, USA
    Headache 40:657-61. 2000
    ..CONCLUSIONS: This pilot study is the first to document a significant drop in cognitive functioning during migraine and recovery after administration of a migraine-specific medication...
  11. ncbi request reprint Clinical efficacy of frovatriptan: placebo-controlled studies
    R Ryan
    Ryan Headache Center, St Louis, MO, USA
    Headache 42:S84-92. 2002
    ..To confirm the clinical efficacy of frovatriptan 2.5 mg...
  12. ncbi request reprint Eletriptan in the early treatment of acute migraine: influence of pain intensity and time of dosing
    J L Brandes
    Nashville Neuroscience Group, Nashville, TN 37203, USA
    Cephalalgia 25:735-42. 2005
    ..Eletriptan was well-tolerated, with adverse event rates similar to placebo when mild headaches were treated...
  13. ncbi request reprint A six-item short-form survey for measuring headache impact: the HIT-6
    M Kosinski
    QualityMetric Incorporated Lincoln, RI 02865, USA
    Qual Life Res 12:963-74. 2003
    ..Migraine and other severe headaches can cause suffering and reduce functioning and productivity. Patients are the best source of information about such impact...
  14. ncbi request reprint A study of the feasibility of Internet administration of a computerized health survey: the headache impact test (HIT)
    M S Bayliss
    QualityMetric Incorporated, Lincoln, RI, USA
    Qual Life Res 12:953-61. 2003
    ....
  15. ncbi request reprint Comparative study of a combination of isometheptene mucate, dichloralphenazone with acetaminophen and sumatriptan succinate in the treatment of migraine
    F G Freitag
    Diamond Headache Clinic, Chicago, Ill 60614-1726, USA
    Headache 41:391-8. 2001
    ..Several parameters suggest that isometheptene mucate, dichloralphenazone with acetaminophen may have a slight advantage compared with sumatriptan succinate in the early treatment of mild-to-moderate migraine...
  16. ncbi request reprint 2000 Wolfe Award. Sumatriptan for the range of headaches in migraine sufferers: results of the Spectrum Study
    R B Lipton
    Albert Einstein Medical College and Montefiore Headache Unit, New York, NY, USA
    Headache 40:783-91. 2000
    ..0005) compared with placebo. CONCLUSION: Sumatriptan, 50-mg tablets, are effective for the full spectrum of headaches experienced by patients with disabling migraine due to a sumatriptan-responsive mechanism...
  17. ncbi request reprint Analgesic rebound headache in clinical practice: data from a physician survey
    A Rapoport
    New England Center for Headache, Stamford, CT 06902, USA
    Headache 36:14-9. 1996
    ..General practitioners, who see a wide variety of patient types with a spectrum of complaints, need to be able to diagnose analgesic rebound headache by taking a good history...